October 3, 2017
- FDA Voice Blog: Expanded Access: FDA Describes Efforts to Ease Application Process
- Compounding Risk Alert: A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation
- Public Notification: A1 Slim contains hidden drug ingredients
- M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry (PDF - 282KB)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Approval Package: Differin Gel
- Drugs@FDA Data Files (updated)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting
.png)
No hay comentarios:
Publicar un comentario